Observed Signal · Nov 6, 2026 · corporate_event · Source: SEC API · Impact: 3.2/5
8-K Financial Filing Analysis for Humana (2026-11-06)
Humana Inc. filed a Form 8-K under Items 2.02 and 7.01 on November 6, 2026, announcing the issuance of its financial results for the third quarter ended September 30, 2026. The company furnished its official press release, detailed earnings release with statistical pages, and management's prepared remarks regarding quarterly performance and future earnings expectations as exhibits. Because the detailed financial statements are furnished via exhibits rather than incorporated directly in the body of the report, the filing functions as an operational notice of Humana's Q3 2026 earnings release.
While this filing marks the formal release of Q3 2026 financial results and forward-looking guidance, the detailed financial tables and operational metrics are furnished via attached exhibits rather than provided directly in the 8-K narrative.
Track Humana Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your Polaris7 workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- Humana furnished its Q3 2026 financial results for the quarter ended September 30, 2026, under Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure).
- The filing incorporates by reference Exhibit 99.1 (Press Release), Exhibit 99.2 (Earnings Release and Statistical Pages), and Exhibit 99.3 (Prepared Management Remarks).
- The filing was executed and certified on November 6, 2026, by John-Paul W. Felter, Senior Vice President, Chief Accounting Officer & Controller.
Connected Companies & Entities
1 Entity mappedRelated Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
8-K Financial Filing Analysis for UnitedHealth Group (2026-10-13)
On October 13, 2026, UnitedHealth Group Incorporated filed a Form 8-K under Item 2.02 (Results of Operations and Financial Condition) announcing the release of its third quarter 2026 financial results via an accompanying press release and related materials furnished as Exhibits 99.1 and 99.2. The filing serves as the formal SEC notification of UnitedHealth Group's Q3 2026 earnings release, although specific financial statements and detailed operational metrics were furnished directly in the referenced exhibits rather than embedded within the text of the report.
8-K Financial Filing Analysis for HP (2026-08-26)
On August 26, 2026, HP Inc. filed a Form 8-K under Item 2.02 (Results of Operations and Financial Condition) announcing that it issued a news release regarding its financial results for the fiscal third quarter ended July 31, 2026. The full operational details and earnings commentary were furnished via Exhibit 99.1 rather than directly filed within the report body. As a standard quarterly earnings disclosure furnished under Item 2.02, it serves to publicly distribute HP's quarterly operating metrics to the market.
8-K Financial Filing Analysis for TransUnion (2026-10-27)
TransUnion furnished a Form 8-K under Items 2.02 and 7.01 announcing its financial results for the third quarter ended September 30, 2026. The filing confirms the distribution of the quarterly earnings press release and the accompanying investor presentation used during the earnings conference call led by executive management. While the detailed income statement and balance sheet schedules were furnished via exhibits, the filing formally initiates the company's Q3 2026 performance review cycle with public markets and institutional investors.
Receive all future signals for Humana & competitors in your briefing
Never miss material M&A deals, leadership changes, account wins, or product rollouts. Polaris7 monitors 20,000+ primary sources 24/7, delivering verified telemetry directly into your executive briefing.